Here are five notes:
1. Zacks Investment Research also upgraded the shares recently from a “hold” to a “buy” rating.
2. Last week, AmSurg shares opened at $64.25.
3. The company has a 12-month high of $87.29 and 12-month low of $57.75.
4. AmSurg’s market cap. is $3.45 billion.
5. The company’s P/E ratio is 19.07.
More articles on surgery centers:
12 new ASCs in October 2016
3 recent ASC acquisitions — November 4, 2016
How physicians and hospitals can benefit from joint ventures
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
